|
NRXP NRX Pharmaceuticals Inc 1719406 |
| Balance Sheet |
|
Current Assets
|
$29,158,000.00 |
|
Assets
|
$34,160,000.00 |
|
Current Liabilities
|
$33,874,000.00 |
|
Liabilities
|
$34,330,000.00 |
|
Equity
|
$-170,000.00 |
|
Shares Out
|
43157744.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,170,000.00 |
|
Investing Cash Flow
|
$-897,000.00 |
| Market Analysis |
Market Cap
|
$151,483,681.44 |
|
Price
|
$3.51 |
|
PB
|
1.38 |
|
EPS
|
-0.44 |
|
PS
|
34.40 |
|
FCF
|
$-13,170,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
|
|
|
2026-05-18 |
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-18 |
-0.98 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NRXP documents filed with the SEC.
NRXP Filings
Clear
